• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti's Micro-Cap Virtual May Conference

    5/9/23 7:15:00 AM ET
    $ATEX
    $AYRO
    $CODA
    $CYTO
    Telecommunications Equipment
    Telecommunications
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $ATEX alert in real time by email

    NEW YORK, NY / ACCESSWIRE / May 9, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day May Micro-cap Conference taking place Wednesday and Thursday, May 10-11, 2023. Presentation schedule is subject to change, please visit www.sidoti.com/events for the most updated version and webinar links. For investor registration and to request 1x1 meetings, please visit https://www.sidoti.com/events/may-micro-cap-virtual-conference.

    Presentation Schedule

    Sidoti & Company, LLC, Monday, May 1, 2023, Press release picture

    *All Times EDT

    Wednesday, May 10th, 2023 (Day 1)

    8:30-9:00

    Coda Octopus Group, Inc. (CODA)

    *****

    Hillstream BioPharma, Inc. (HILS)

    SosTravel.com SpA (SOSAF)

    9:15-9:45

    ReWalk Robotics (RWLK)

    GigaCloud Technology Inc (GCT)

    ZyVersa Therapeutics (ZVSA)

    Netcapital Inc (NCPL)

    10:00-10:30

    Guerrilla RF, Inc. (GUER)

    Bion Environmental Technologies (BNET)

    Lisata Therapeutics (LSTA)

    Acme United Corporation (ACU)

    10:45-11:15

    *****

    Lee Enterprises (LEE)

    NeuroOne Medical Tech (NMTC)

    Innovative Solutions & Support (ISSC)

    11:30-12:00

    Anterix (ATEX)

    SAB Biotherapeutics Inc. (SABS)

    Harvard Bioscience (HBIO)

    LifeMD (LFMD)

    12:15-12:45

    Spectra7 Microsystems (SEV)

    LifeVantage Corporation (LFVN)

    TFF Pharmaceuticals (TFFP)

    AYRO, Inc. (AYRO)

    1:00-1:30

    PCTEL (PCTI)

    *****

    Altamira Therapeutics Ltd. (CYTO)

    Corus Entertainment Inc. (CJR.B)

    1:45-2:15

    *****

    Aterian Inc. (ATER)

    Baudax Bio (BXRX)

    BlackSky Technology Inc. (BKSY)

    2:30-3:00

    *****

    Black Diamond Group (BDI)

    Synlogic Inc (SYBX)

    Innovative Eyewear, Inc. (LUCY)

    3:15-3:45

    Amesite Inc. (AMST)

    ARC Document Solutions (ARC)

    *****

    *****

    4:00-4:30

    Mawson Infrastructure Group (MIGI)

    *****

    Kintara Therapeutics, Inc. (KTRA)

    *****

    1x1s Only

    (10th)

    Hooker Furnishings Corp (HOFT)

    Manitex International (MNTX)

    *****

    *****

    *All Times EDT

    Thursday, May 11th, 2023 (Day 2)

    8:30-9:00

    *****

    Polypid Ltd. (PYPD)

    HydroGraph Clean Power Inc. (HG)

    *****

    9:15-9:45

    Orange Polska (OPL)

    AnPac Bio-Medical Science (ANPC)

    InfuSystem Holdings Inc. (INFU)

    Olympic Steel, Inc. (ZEUS)

    10:00-10:30

    Intellicheck (IDN)

    VersaBank (VBNK)

    *****

    Quadient (QDT)

    10:45-11:15

    CPS Technologies Corp. (CPSH)

    Apogee Enterprises, Inc. (APOG)

    Virpax Pharmaceuticals, Inc. (VRPX)

    AstroNova, Inc (ALOT)

    11:30-12:00

    Quad/Graphics (QUAD)

    Mistras Group, Inc. (MG)

    Genenta Science (GNTA)

    Argentina Lithium & Energy (PNXLF)

    12:15-12:45

    *****

    Heliogen (HLGN)

    Genprex, Inc. (GNPX)

    The Real Brokerage Inc (REAX)

    1:00-1:30

    SOBR Safe Inc (SOBR)

    Powell Industries, Inc. (POWL)

    Humacyte, Inc. (HUMA)

    Townsquare Media Inc (TSQ)

    1:45-2:15

    Inhibikase Therapeutics, Inc. (IKT)

    Smart Sand, Inc. (SND)

    LogicMark (LGMK)

    Exco Technologies (XTC)

    2:30-3:00

    *****

    Sterling Infrastructure, Inc. (STRL)

    Coya Therapeutics, Inc. (COYA)

    *****

    3:15-3:45

    *****

    Carbon Streaming Corp (OFSTF)

    FSD Pharma Inc. (HUGE)

    *****

    4:00-4:30

    *****

    Super League Gaming, Inc (SLGG)

    Cardiol Therapeutics, Inc. (CRDL)

    *****

    1x1s Only

    (11th)

    Beazer Homes USA, Inc. (BZH)

    FGI Industries (FGI)

    Hooker Furnishings Corp (HOFT)

    *****

    About Sidoti & Company, LLC
    For nearly 25 years, Sidoti & Company, LLC (www.sidoti.com) has been a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises upwards of 200 names of which about one-third participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Sidoti is also a leading provider of corporate access through the eight investor conferences it hosts each year. Our small- and microcap-focused nationwide sales force, which has relationships with approximately 500 institutional clients in North America, enables the firm to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/753555/Sidotis-Micro-Cap-Virtual-May-Conference

    Get the next $ATEX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEX
    $AYRO
    $CODA
    $CYTO

    CompanyDatePrice TargetRatingAnalyst
    SAB Biotherapeutics Inc.
    $SABS
    9/17/2025$7.00Outperform
    Leerink Partners
    LifeMD Inc.
    $LFMD
    6/18/2025$15.00 → $18.00Buy
    BTIG Research
    SAB Biotherapeutics Inc.
    $SABS
    5/14/2025$10.00Buy
    H.C. Wainwright
    NeuroOne Medical Technologies Corporation
    $NMTC
    5/5/2025$1.45Buy
    Ladenburg Thalmann
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    GigaCloud Technology Inc
    $GCT
    3/4/2025$32.00 → $15.00Buy → Neutral
    ROTH MKM
    Lifevantage Corporation
    $LFVN
    1/14/2025$35.00Buy
    Craig Hallum
    Lifevantage Corporation
    $LFVN
    12/19/2024$26.00Buy
    Lake Street
    More analyst ratings

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement

    Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to address difficult-to-treat diseases Catalent's preclinical study results provide proof-of-concept support for leveraging certepetide-related biology through its use as an ADC payload BASKING RIDGE, N.J. and TAMPA, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, and Catalent, Inc. ("Catalent"), a leader in enabling the development and supply of better treatme

    10/8/25 8:30:00 AM ET
    $LSTA
    Misc Health and Biotechnology Services
    Health Care

    LifeVantage Announces Closing of LoveBiome Acquisition

    SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transaction, LifeVantage has acquired LoveBiome's critical operating assets essential to the microbiome health business, including the retention of key LoveBiome personnel. "We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Ols

    10/2/25 8:00:00 AM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

    NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month. Through LifeMD's integration with NovoCare® Pharmacy, eligible self-pay and uninsured patients, as well as insured patients whose plans do not cover GLP-1 therapies, now have direct access to all FDA-approved dose strengths of Ozempic® within LifeMD's end-to-end virtual care platform. LifeMD's telehealth platform is seamlessly integrated with NovoCare® Pharmacy to provide easy, rel

    9/30/25 8:00:00 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Lang Scott A. bought $98,952 worth of shares (4,650 units at $21.28) (SEC Form 4)

    4 - Anterix Inc. (0001304492) (Issuer)

    9/19/25 8:57:12 AM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    Director Lewis Darwin bought $4,882 worth of shares (450 units at $10.85), increasing direct ownership by 0.39% to 117,217 units (SEC Form 4)

    4 - Lifevantage Corp (0000849146) (Issuer)

    9/18/25 4:36:17 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Gray Timothy bought $1,104 worth of shares (50 units at $22.07), increasing direct ownership by 0.06% to 77,022 units (SEC Form 4)

    4 - Anterix Inc. (0001304492) (Issuer)

    8/21/25 9:19:26 AM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Strawn John R Jr was granted 22,365 shares, increasing direct ownership by 6% to 413,001 units (SEC Form 4)

    4 - LifeMD, Inc. (0000948320) (Issuer)

    10/8/25 6:25:50 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Director Larovere Joan was granted 22,365 shares, increasing direct ownership by 26% to 107,050 units (SEC Form 4)

    4 - LifeMD, Inc. (0000948320) (Issuer)

    10/8/25 6:03:32 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Director Denelsky Stephen J was granted 110,000 shares (SEC Form 4)

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    10/7/25 1:28:32 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Leerink Partners initiated coverage on SAB BIO with a new price target

    Leerink Partners initiated coverage of SAB BIO with a rating of Outperform and set a new price target of $7.00

    9/17/25 8:03:24 AM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BTIG Research reiterated coverage on LifeMD with a new price target

    BTIG Research reiterated coverage of LifeMD with a rating of Buy and set a new price target of $18.00 from $15.00 previously

    6/18/25 10:55:14 AM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    H.C. Wainwright resumed coverage on SAB BIO with a new price target

    H.C. Wainwright resumed coverage of SAB BIO with a rating of Buy and set a new price target of $10.00

    5/14/25 9:00:46 AM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ATEX
    $AYRO
    $CODA
    $CYTO
    SEC Filings

    View All

    Anterix Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Anterix Inc. (0001304492) (Filer)

    10/9/25 4:30:53 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    Lisata Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - LISATA THERAPEUTICS, INC. (0000320017) (Filer)

    10/8/25 3:12:42 PM ET
    $LSTA
    Misc Health and Biotechnology Services
    Health Care

    NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)

    10/6/25 4:19:29 PM ET
    $NMTC
    Medical/Dental Instruments
    Health Care

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Leadership Updates

    Live Leadership Updates

    View All

    Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

    HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board's Nominating and Governance Committee. "We are pleased to announce Steve as the newest member of our Board of Directors at such an important time for Harvard Bioscience," said John Duke, President & CEO. "His knowledge across the verticals we operate in, as well as his expertise in guiding life sciences companies on financial strategy will be invaluable as we move forward." "I'm honored to join the Board and lo

    9/9/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness

    SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions.* LoveBiome has established itself as a leader in the emerging microbiome health sector, focusing on the critical connection between gut health and overall wellness. The company's innovative P84 product takes the guesswork out of gut health, regulating, repairing, and restoring the gut and microbiome th

    9/3/25 5:00:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GigaCloud Technology Inc Appoints Highly Respected Industry Veteran Kerry Lebensburger to Board of Directors

    EL MONTE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (NASDAQ:GCT) ("GigaCloud" or the "Company"), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced the appointment of industry leader Kerry Lebensburger to its Board of Directors (the "Board"), effective August 17, 2025, succeeding retiring member Lorri Kelley. GigaCloud's Board membership remains at five. Lebensburger brings decades of executive leadership experience as the former President of Ashley Furniture, one of the largest furniture companies in the U.S., where he served for nearly 30 years before retiring in 2023. During his tenure, Lebensburger advanced th

    8/18/25 6:00:00 AM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Financials

    Live finance-specific insights

    View All

    LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

    NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ:LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2025, to holders of record at the close of business on October 3, 2025. About LifeMD, Inc.LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's

    9/23/25 4:05:00 PM ET
    $LFMD
    Medical/Nursing Services
    Health Care

    Netcapital Announces First Quarter Fiscal 2026 Financial Results

    Management to Host Earnings Call on September 23, 2025 at 10 a.m. ET BOSTON, MA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a digital private capital markets ecosystem, today announced financial results for the first quarter of fiscal year 2026 ended July 31, 2025. "We are pleased to report that we began our fiscal year 2026 with revenue growth of more than 30% for the first quarter. In fiscal year 2025, we shifted our strategy to focus on building a stronger and more scalable business, and we are encouraged to see our vision taking shape," said Martin Kay, CEO of Netcapital Inc. "We achieved several significant milestones during the quarte

    9/22/25 4:54:50 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Coda Octopus Group Reports Fiscal Third Quarter 2025 Financial Results

    ORLANDO, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. ("CODA" or the "Company") (NASDAQ:CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology for real-time subsea intelligence and cutting-edge diving technology, today reported its unaudited financial results for its fiscal third quarter ended July 31, 2025 (TQ2025). Annmarie Gayle, CODA's Chairman and CEO, commented: "I am pleased with our overall results of operations in TQ2025, especially the increase in revenue by 29.0%. Despite the fluid global policy setting environment, we continue to invest in our growth strategy and have made good progress under the DAVD Program. In the TQ2025 we had DAVD

    9/15/25 7:00:00 AM ET
    $CODA
    Industrial Machinery/Components
    Industrials

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by GigaCloud Technology Inc

    SC 13D/A - GigaCloud Technology Inc (0001857816) (Subject)

    12/12/24 3:02:53 PM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Anterix Inc.

    SC 13D/A - Anterix Inc. (0001304492) (Subject)

    12/9/24 8:45:15 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by NeuroOne Medical Technologies Corporation

    SC 13G/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)

    11/26/24 8:42:10 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care